During the past decade, Berma Research Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Berma Research Group" #1 sponsor was "Pfizer" with 4 trials, followed by "Eisai Inc." with 2 trials sponsored, "Epix Pharmaceuticals, Inc." with 2 trials sponsored, "Forest Laboratories" with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Berma Research Group" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Berma Research Group" are "Alzheimer's Disease" (12 trials), "Alzheimer Disease" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Osteoarthritis" (2 trials) and "Schizophrenia" (2 trials). Many other conditions were trialed in "Berma Research Group" in a lesser frequency.

Most popular intervention types in "Berma Research Group" are "Drug" (23 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AVP-786" (2 trials), "PRX-03140" (2 trials), "tanezumab" (2 trials) and "3APS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Berma Research Group" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Berma Research Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Berma Research Group, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Berma Research Group, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".